Glaukos Corp (GKOS) - Product Pipeline Analysis, 2017 Update

2017-05-18
Price :
Published : May-2017
No. of Pages : 45
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Glaukos Corp Company Overview 5
Glaukos Corp Company Snapshot 5
Glaukos Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Glaukos Corp - Pipeline Analysis Overview 8
Glaukos Corp - Key Facts 8
Glaukos Corp - Major Products and Services 9
Glaukos Corp Pipeline Products by Development Stage 10
Glaukos Corp Ongoing Clinical Trials by Trial Status 12
Glaukos Corp Pipeline Products Overview 14
GTS400 14
GTS400 Product Overview 14
iDose Travoprost Intraocular Implant 15
iDose Travoprost Intraocular Implant Product Overview 15
iDose Travoprost Intraocular Implant Clinical Trial 16
IOP Sensor System 17
IOP Sensor System Product Overview 17
iStent Inject - Cataract Surgery 18
iStent Inject - Cataract Surgery Product Overview 18
iStent Inject - Cataract Surgery Clinical Trial 19
iStent Inject - Standalone Procedures 21
iStent Inject - Standalone Procedures Product Overview 21
iStent Inject - Standalone Procedures Clinical Trial 22
iStent Supra Suprachoroidal Micro-Bypass Stent 24
iStent Supra Suprachoroidal Micro-Bypass Stent Product Overview 24
iStent Supra Suprachoroidal Micro-Bypass Stent Clinical Trial 25
Glaukos Corp - Key Competitors 26
Glaukos Corp - Key Employees 27
Glaukos Corp - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Glaukos Corp, Recent Developments 29
May 03, 2017: Glaukos Announces First Quarter 2017 Financial Results 29
May 03, 2017: Glaukos Completes Patient Enrollment in Phase II Clinical Trial for iDose Travoprost Intraocular Implant in Glaucoma Patients 29
May 02, 2017: Several Surgeon Presentations to Include Glaukos Technologies at 2017 American Society of Cataract and Refractive Surgery 30
May 01, 2017: Several Surgeon Presentations to Include Glaukos Technologies at 2017 American Society of Cataract and Refractive Surgery 32
Apr 13, 2017: International Study Shows Two Glaukos iStent Trabecular Micro-Bypass Stents and One Topical Medication Deliver Sustained IOP Reduction 35
Mar 16, 2017: Glaukos Announces Five-Year Extensions For Three Category III CPT Codes Related To Micro-Invasive Glaucoma Surgery 36
Mar 01, 2017: Glaukos Announces Fourth Quarter & Full Year 2016 Financial Results 37
Feb 28, 2017: Glaukos Technologies Featured in Eight Presentations at 2017 American Glaucoma Society Meeting 38
Feb 22, 2017: Preeminent Ophthalmologist, L. Jay Katz Joins Glaukos as Chief Medical Officer 40
Feb 16, 2017: Glaukos Completes Patient Enrollment in Pivotal Phase of U.S. IDE Clinical Trial for iStent SUPRA 40
Appendix 42
Methodology 42
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Glaukos Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Glaukos Corp Pipeline Products by Equipment Type 6
Glaukos Corp Pipeline Products by Indication 7
Glaukos Corp Ongoing Clinical Trials by Trial Status 7
Glaukos Corp, Key Facts 8
Glaukos Corp, Major Products and Services 9
Glaukos Corp Number of Pipeline Products by Development Stage 10
Glaukos Corp Pipeline Products Summary by Development Stage 11
Glaukos Corp Ongoing Clinical Trials by Trial Status 12
Glaukos Corp Ongoing Clinical Trials Summary 13
GTS400 - Product Status 14
GTS400 - Product Description 14
iDose Travoprost Intraocular Implant - Product Status 15
iDose Travoprost Intraocular Implant - Product Description 15
iDose Travoprost Intraocular Implant - Assessment of iDose Delivery System's Safety and Preliminary Efficacy for the Reduction of Elevated Intraocular Pressure 16
IOP Sensor System - Product Status 17
IOP Sensor System - Product Description 17
iStent Inject - Cataract Surgery - Product Status 18
iStent Inject - Cataract Surgery - Product Description 18
iStent Inject - Cataract Surgery - A Prospective, Randomized Evaluation of Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004% 19
iStent Inject - Cataract Surgery - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery 20
iStent Inject - Cataract Surgery - A Randomized Controlled Trial of Cataract Surgery Versus Combined Cataract Surgery with Insertion of iStent Inject 20
iStent Inject - Standalone Procedures - Product Status 21
iStent Inject - Standalone Procedures - Product Description 21
iStent Inject - Standalone Procedures - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication (Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) 22
iStent Inject - Standalone Procedures - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperative Topical Prostaglandin 22
iStent Inject - Standalone Procedures - Initial Phase of U.S. IDE Clinical Trial for Standalone Version of iStent inject 23
iStent Inject - Standalone Procedures - The Effect of Glaucoma Surgery on Aqueous Dynamics in Patients With Glaucoma or Ocular Hypertension: An Observational Study 23
iStent Supra Suprachoroidal Micro-Bypass Stent - Product Status 24
iStent Supra Suprachoroidal Micro-Bypass Stent - Product Description 24
iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated with One Suprachoroidal Stent 25
iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin 25
iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction with Cataract Surgery 25
Glaukos Corp, Key Employees 27
Glaukos Corp, Subsidiaries 28
Glossary 43

List of Figures
Glaukos Corp Pipeline Products by Equipment Type 6
Glaukos Corp Pipeline Products by Development Stage 10
Glaukos Corp Ongoing Clinical Trials by Trial Status 12
Filed in: Medical Device
Publisher : GlobalData